The Canadian Clinical Trials Asset Map (CCTAM) is a unique, robust, searchable web-based database designed to showcase Canada's clinical research strengths. It is the first pan-Canadian research inventory with an integrated map-based search function that lists Canadian investigators, clinical research sites, hospitals, institutions, research ethics boards and other clinical research resources available across the country.
Its purpose is to:
- Showcase the tremendous assets available in Canada to conduct clinical trials
- Provide a comprehensive database of all Canadian clinical research assets; better enabling sponsors of clinical trials to identify clinical research sites and investigators.
- Allow for easy navigation of the Canadian clinical trials landscape and expedite study feasibility analysis for trial sponsors
- Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace.
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and caregivers, researchers, health practitioners, policy makers, provincial/territorial health authorities, academic institutions, charities, and private sector) dedicated to the integration of research into care.
The objective of SPOR is to foster evidence-informed health care by bringing innovative diagnostic and therapeutic approaches to the point of care, so as to ensure greater quality, accountability, and accessibility of care.
Innovative Medicines Canada (formerly known as Rx&D) is the association of leading research-based pharmaceutical companies dedicated to improving the health of all Canadians through the discovery, development, and delivery of new medicines and vaccines.
As the national voice of research-based pharmaceutical companies, Innovative Medicines Canada advocates for policies that enable the discovery, development, and commercialization of innovative medicines and vaccines that will improve the lives of all Canadians. They support their members' commitment to being value partners in the Canadian healthcare system.
HealthCareCAN is the national voice of healthcare organizations in Canada. They foster informed and continuous, rsults oriented discovery and innovation across the continuum of healthcare. They act with others to enhance the health of all Canadians; to build the capability for high quality care; and to help ensure value for money in publicly financed, healthcare programs.